comparemela.com

Latest Breaking News On - ப்ர்யாக்டீஸ் வழிகாட்டுதல்கள் - Page 23 : comparemela.com

Mānoa: Hawaiʻi, national cancer organizations warn cancer doesn t stop for COVID-19 and neither should you

HONOLULU, HI, ATLANTA, GA and PLYMOUTH MEETING, PA, January 28, 2021 The University of Hawaii Cancer Center and the Hawaii Cancer Consortium are  teaming up with the National Comprehensive Cancer Network® (NCCN®), the American Cancer Society (ACS) and other leading cancer organizations across the country to endorse the resumption of cancer screening and treatment during the ongoing COVID-19 pandemic. The coalition of 76 organizations has released an open letter reminding the public that cancer still poses a major threat to people’s health, but acting as soon as is safely possible can lead to much better outcomes in the future. The letter examines distressing trends showing a significant drop-off in recommended cancer screening and treatment compared to prior years. This concerning side-effect of the pandemic could lead to a staggering number of preventable cancer deaths over the next ten years and beyond. Oncology experts agree that people should not delay any necessary preve

White House Kills Expanded Buprenorphine Access (At Least for Now), Mexican Poppy Farmers Tell Army to Get Lost, More (1/28/21)

Mexican opium poppy farmers are demanding the army quit destroying their crops and leave the area. (UNODC) Marijuana Policy South Dakota Judge Hears Arguments on Marijuana Amendment. A state judge in Pierre presided over nearly three hours of arguments Wednesday from attorneys challenging and defending the state s voter-approved marijuana legalization constitutional amendment. The constitutionality of the amendment is being challenged by the head of the Highway Patrol and the Pennington County sheriff, with the support of Gov. Kristi Noem (R). Ironically, Noem s attorney general, Jason Ravnsborg, is part of the team defending the amendment. The judge said she would issue a written opinion but gave no timeline for doing so.

Daiichi Sankyo Company, Limited: Datopotamab Deruxtecan and ENHERTU Show Promising Early Clinical Activity in Patients with Advanced Non-Small Cell Lung Cancer

Daiichi Sankyo Company, Limited: Datopotamab Deruxtecan and ENHERTU Show Promising Early Clinical Activity in Patients with Advanced Non-Small Cell Lung Cancer ii 80% (n=64) CI, confidence interval; CR, complete response; DCR, disease control rate; NE, not evaluable; ORR, objective response rate; PD, progressive disease; PR, partial response i Includes patients with =1 postbaseline scan or who discontinued treatment. ii ORR is CR+PR; Responses are confirmed (CRs/PRs; n=32) plus those CRs/PRs too early to be confirmed (n=5). iii DCR is CR+PR+SD iv Preliminary PFS limited by earlier censoring by data cutoff due to immature duration of follow-up for 4 and 6 mg/kg dose cohorts.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.